A61K 35/74 Bacteria (therapeutic use of a bacterial protein A61K38/00)
Introduced: July 1974
Title
Titles differ between systems:
IPC: Bacteria
CPC: Bacteria (therapeutic use of a bacterial protein A61K38/00)
Full Title
Full titles differ between systems:
Medicinal preparations containing materials or reaction products thereof with undetermined constitution > Microorganisms or materials therefrom > Bacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution > Microorganisms or materials therefrom (fungi, yeasts or candida A61K36/06) > Bacteria (therapeutic use of a bacterial protein A61K38/00)
IPC and CPC are identically structured here. All 2 subcodes exist in both systems.
2 shared codes have differing titles between IPC and CPC.
IPC defines codes here since 2015.
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 35/741 Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06) since 2015 IPC+CPC Available in IPC and CPC
- A61K 35/748 Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina (algae, microalgae or microphytes A61K36/02) since 2015 IPC+CPC Available in IPC and CPC
Top Applicants
Top Applicants (IPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594
Top Applicants (CPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513